Envestnet Asset Management Inc Cardiol Therapeutics Inc. Transaction History
Envestnet Asset Management Inc
- $302 Billion
- Q4 2024
A detailed history of Envestnet Asset Management Inc transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 309,684 shares of CRDL stock, worth $390,201. This represents 0.0% of its overall portfolio holdings.
Number of Shares
309,684Holding current value
$390,201% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding CRDL
# of Institutions
46Shares Held
6.79MCall Options Held
5.2KPut Options Held
9.5K-
Tejara Capital LTD London, X03.12MShares$3.93 Million2.61% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD1.17MShares$1.48 Million0.46% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9796KShares$1 Million0.31% of portfolio
-
Cambridge Investment Research Advisors, Inc.331KShares$416,4360.0% of portfolio
-
Lion Street Advisors, LLC308KShares$387,6590.13% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $78M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...